SCOTLAND AND UNITED KINGDOM, NOV 12, 2019 -- A new technology which aims to revolutionize the way the world’s wastewater can be processed has delivered promising results at an extensive UK trial.
A trial of Microvi’s MNE™ technology has been completed at Scottish Water’s Wastewater Development Centre at Bo’ness, by the Research and Innovation team.
Microvi, a green technology company based in California, in collaboration with Scottish Water carried out a six-month trial of the process at the center near Falkirk. It is part of a range of next-generation bio-technologies the US firm has designed for the water, wastewater and renewable chemical industries.
During the trial the plant treated primary settled effluent taken from the Bo’ness Wastewater Treatment Works primary tanks which are situated right next to the test center.
The main objective of the trial was to establish if Microvi’s MNE technology can achieve treatment performance of total BOD (Biological Oxygen Demand) and TSS (total suspended solids) of minimum 20 mg/l and Ammonia of minimum 5 mgN/l, which is the typical effluent consent requirement.
It was also to test if the Microvi MNE can achieve much tighter standards and reduce the amount of ammonia in the final effluent – with a target of total BOD and TSS of 5 mg/l and Ammonia of 1 mgN/l. This is was an important element to the trial as wastewater sites face tightening consent requirements and finding out if this technology can achieve very low targets was one of aims of the project.
The technology uses specially selected, naturally occurring bacteria which consume pollutants in wastewater. It creates an optimum environment for these bacteria – known as biocatalysts - to make them work more efficiently. It is designed to intensify the population of the bacteria and speed up the rate these good bacteria out-compete the bad bacteria.
The technology aims to drastically reduce the amount of sludge produced. This happens as a result of the biocatalyst creating an environment where bacteria reproduction is limited. Reducing sludge cuts the energy, transport and chemical requirements to manage bio-solids and in turn means far less space needed for the treatment process.
The results of the trial confirmed the Microvi MNE process can treat ammonia and soluble BOD to below levels of detection at high flow and high organic loading rates.
It showed that under normal operating conditions the effluent consistently achieves effluent ammonia concentration below 1 mg/l with an HRT (hydraulic retention time) of around 4 hours – around half the time of other comparable current technologies including conventional Activated Sludge Process.
It also found that high levels of ammonia removal can also be achieved even at 2.3 hours HRT at temperatures as low as 10C, a considerable reduction against existing processes
The trial also confirmed there was no net generation of sludge through the removal of ammonia and BOD with an average zero percentage change in sludge over the test period, which can lead to significant capital and operating cost benefits in the treatment and disposal of biosolids
It confirmed Microvi's wastewater technology has significant advantages over conventional water treatment processes. It requires a smaller footprint and does not generate biological solids, while removing BOD, ammonia, phosphorus and nitrate. The solution is easy to use and can be used in existing infrastructure.
George Ponton, Head of Research and Innovation at Scottish Water welcomed the results of the trial. He said: “The trial has highlighted the potential this innovative technology has to meet BOD and ammonia standards in a smaller footprint than conventional activated sludge systems. It showed Microvi can be an effective technology for process intensification at wastewater treatment works, allowing us to enable growth using less energy and a lower carbon footprint.
“This technology, has the potential to be part of our future asset base, enabling sustainable growth and improving process efficiency at Scottish Water’s treatment works.“
